[Therapeutic approach in pregnant women with an autoimmune thrombocytopenic purpura].
The case presented herein aim to update the existing information about the common diagnostic problems and therapeutic approach in pregnant women that have autoimmune thrombocytopenic purpura (ATP).
R
R
Christova
T
T
Lisichkov
T
T
Chernev
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D036861:Delivery, Obstetric; D015942:Factor VIIa / Q000627:therapeutic use; D005260:Female; D005942:Gluconates / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007231:Infant, Newborn; D017713:Platelet Transfusion; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D005942:Gluconates; D007136:Immunoglobulins; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa; C030691:gluconic acid